MacroGenics, Inc.
MGNX
$1.81
$0.1710.37%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 34.88% | 21.37% | 66.53% | 220.78% | -196.86% |
| Total Depreciation and Amortization | 5.30% | -3.80% | 8.05% | -5.90% | -35.60% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -31.18% | -5.19% | -909.72% | 113.32% | 106.64% |
| Change in Net Operating Assets | -662.40% | -8,106.71% | -79.33% | 52.91% | -90.87% |
| Cash from Operations | -5.62% | -2.73% | -36.99% | 270.69% | -2,029.49% |
| Capital Expenditure | 30.92% | 63.74% | 0.00% | -18.64% | -261.89% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | 700.00% | 48.15% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -176.30% | -60.27% | 6.71% | 209.31% | 142.73% |
| Cash from Investing | -179.34% | -60.06% | 6.81% | 206.19% | 141.80% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -89.54% | -- | -41.97% | -88.46% | 184.23% |
| Repurchase of Common Stock | 100.00% | 88.21% | -- | 47.52% | 14.29% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 11,058.24% | -213.71% | -43.22% | -100.14% | 959.32% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -516.10% | -80.91% | -70.93% | 607.39% | 103.10% |